Offerpad's Q4 results fell short of analysts' estimates, with disappointing revenue, EBITDA, and EPS. The company's stock is down 1.1% and currently trades at $9.1 per share.
Despite promising growth forecasts, Offerpad Solutions' P/S ratio is significantly lower than most industry peers, which could indicate major risk factors putting downward pressure on its stock. Potential volatility in future revenues could be a concern for investors.
Offerpad Solutions股票討論區
Going to 11.00
專欄Top upgrades and downgrades on 6/21: XOM, ADBE, UAA, BEKE and more
• $反導工業(ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $美國電塔(AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $丘奇&德懷特(CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy(CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $康西哥(CNC.US)$ : Credit Suisse Upgrades to Outperform from...
專欄Top upgrades and downgrades on 3/30
• $Beacon Roofing Supply(BECN.US)$: JPMorgan Upgrades to Neutral from Underweight - PT $68
• $HF Sinclair(DINO.US)$ : Goldman Sachs Upgrades to Neutral from Sell - PT $43 (from $32)
• $Freshpet(FRPT.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $136
• $HealthEquity(HQY.US)$ : BTIG Upgrades to Buy from Neutral - PT $85
• $美國豪斯特酒店(HST.US)$ : Jefferies Upgrades to Buy from Hold - PT $25 (from $20)
• $馬斯科(MAS.US)$ : JPMorgan...
These stocks will bring EASY MONEY GAINS LINK BELOW
🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨
$SPDR 標普500指數ETF(SPY.US)$$AMC院線(AMC.US)$$Camber Energy(CEI.US)$$Eledon Pharmaceuticals(ELDN.US)$$Offerpad Solutions(OPAD.US)$$Sphere 3d(ANY.US)$$WSB熱門概念(BK2555.US)$$先驅電氣(PPSI.US)$$蘋果(AAPL.US)$$富途控股(FUTU.US)$$蔚來(NIO.US)$$奈飛(NFLX.US)$
暫無評論